Qingchun Xu

机构：Jinan University, Ludong University, Wuhu Fourth People Hospital, Shantou Central Hospital, Xian Yang Central Hospital

发表论文 21 篇 · 总被引 133 次 · h-index 6

代表论文

• A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer (2023 · Advanced Science · 被引 46)
• The Effect of Daily Fluid Management and Beverages Consumption on the Risk of Bladder Cancer: A Meta-analysis of Observational Study (2018 · Nutrition and Cancer · 被引 19)
• Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma (2021 · Bioscience Reports · 被引 17)
• Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma (2020 · Journal of Computational Biology · 被引 8)
• Photocatalytic 2‐Iodoethanol Coupling to Produce 1,4‐Butanediol Mediated by TiO 2 and a Catalytic Nickel Complex (2023 · Angewandte Chemie International Edition · 被引 6)
• Evaluation of Serum miR-216a, miR-216b, miR-217, miR-92b, miR-375and miR-148a as Potential Biomarkers for Acute Pancreatitis and the Roleof miR-92b in Attenuating Caerulein-induced Injury and InflammatoryResponses in AR42J Cells (2023 · Combinatorial Chemistry & High Throughput Screening · 被引 6)